Plain-English translation of NCT06737549 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
After a stroke, many people have trouble swallowing safely. This trial is testing a combination approach using electroacupuncture (a type of acupuncture with mild electrical stimulation) along with NGF (a protein that helps nerves heal and regrow). The theory is that the acupuncture may help NGF reach the brain more effectively, working together to improve swallowing and brain recovery.
Currently, doctors don't have very effective treatments for swallowing problems after stroke. NGF is promising for nerve healing, but it's hard for it to cross into the brain on its own. This trial explores whether combining it with acupuncture could overcome that barrier and create a better treatment option.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to one of four groups: acupuncture with the nerve growth protein, acupuncture with a placebo (inactive treatment), standard acupuncture with the protein, or standard acupuncture with placebo. You would receive regular acupuncture or electroacupuncture treatments and injections over the course of the study. You would also have swallowing tests and other assessments to measure any improvements in your ability to swallow and your overall recovery.
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
China